Table 3.

IBD outcome measures and labs.

Lab	Reference range and units	Before histoplasmosis diagnosis	At time of histoplasmosis diagnosis	1‐Year post‐histoplasmosis diagnosis	2‐Year posthistoplasmosis diagnosis
Days from histoplasmosis diagnosis,a median [IQR]		69 [104–38]	0 [0–12]	378 [341–416]	762 [733–794]
sPCDAI, median [IQR]		0 [0–13]	5 [0–19]	0 [0–10]	5 [0–8]
PUCAI, median [range]		30 [0–55]	65 [20–70]	20 [0–25]	0 [0–10]
PGA, % quiescent		79%	74%	72%	80%
Albumin, median [IQR]	3.4–5.2 g/dL	4.25 [4.1–4.5]	4.1 [3.6–4.4]	4.3 [4.1–4.6]	4.3 [4.0–4.5]
Hemoglobin, median [IQR]	13.5–18.0 g/dL	12.7 [11.7–15.0]	13.3 [11.2–14.8]	12.8 [12.0–14.4]	13.4 [12.4–14.7]
ESR, median [IQR]	<15 mm/h	16 [8.0–28.5]	27 [20–47]	14 [8.3–24]	11 [9–13]
CRP, median [IQR]	<1.0 mg/dL	0.3 [0.0–0.95]	1.0 [0.7–3.3]	0.6 [0.0–1.4]	0.0 [0.0–0.85]

Abbreviations: CRP, C‐reactive protein; ESR, erythrocyte sedimentation rate; IBD, inflammatory bowel disease; IQR, interquartile range; PGA, Physician Global Assessment; PUCAI, Pediatric Ulcerative Colitis Activity Index; sPCDAI, Short Pediatric Crohn's Disease Activity Index.

^aDays refer to when measurement occurred.